Leukemia inhibitory factor (LIF), a member of the interleukin‐6 cytokine family, plays a
complex role in cancer. LIF inhibits the proliferation and survival of several myeloid leukemia …

Leukemia Inhibitory Factor (LIF) is a member of the IL-6 cytokine family and is expressed in
almost every tissue type within the body. Although LIF was named for its ability to induce …

Leukemia inhibitory factor (LIF) is a multi-functional cytokine of the interleukin-6 (IL-6)
superfamily. Initially identified as a factor that inhibits the proliferation of murine myeloid …

Leukemia inhibitory factor (LIF) affects the growth of carcinoma cells, and we thus analyzed
its underlying mechanisms. Carcinoma cells constitutively express LIF mRNA, and 23 lines …

Leukemia inhibitory factor (LIF), a cytokine that belongs to the interleukin-6 family, regulates
multiple important biological functions. Recently, we found that LIF is an important negative …

Leukemia inhibitory factor (LIF) is a pleiotropic cytokine of the interleukin-6 (IL-6)
superfamily. LIF was initially discovered as a factor to induce the differentiation of myeloid …

Leukemia inhibitory factor (LIF) is a pleiotrophic cytokine, which plays an important role in
inducing cancer cachexia. We have previously reported that LIF promotes cell proliferation …

Leukemia‐inhibitory factor (LIF) is an inflammatory cytokine with pleiotropic activities. LIF
was originally described as a differentiation factor of a murine leukemia cell line and was …

The long‐term outcome of gastric cancer (GC) patients remains unsatisfactory despite some
recent improvements. Leukemia inhibitory factor (LIF) is a prognostic biomarker for some …

Leukemia inhibitory factor (LIF), a secreted cytokine, plays an important role in a wide array
of biological processes including inducing differentiation of leukemia cell, inflammatory …